Gene Editing Firm, Graphite Bio, Takes +85,000 SQFT Lease at Nexus on Grand in South San Francisco

Next-generation gene editing company to occupy three full floors of ground-up, Class A life sciences development in one of the top biotech markets in the U.S. SAN FRANCISCO – (January 26, 2022) – Savills announced that it completed an 85,165-square-foot lease relocation and expansion on behalf of Graphite Bio, Inc. (NASDAQ: GRPH) at 233 East Grand Avenue, a Class […]